Detalhe da pesquisa
1.
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer.
BMC Cancer
; 19(1): 880, 2019 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31488078
2.
Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.
Breast Care (Basel)
; 3(2): 128-133, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-21373217